Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OGN | Common Stock | Options Exercise | +4.43K | +97.26% | 8.99K | May 4, 2022 | Direct | F1 | ||
transaction | OGN | Common Stock | Tax liability | -$42.1K | -1.3K | -14.45% | $32.44 | 7.69K | May 4, 2022 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -4.43K | -50% | $0.00 | 4.43K | May 4, 2022 | Common Stock | 4.43K | Direct | F1, F2, F3 |
Id | Content |
---|---|
F1 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU. |
F2 | The amount of the RSUs has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. |
F3 | On May 4, 2022, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on May 4, 2023 and May 4, 2024. |